nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC3—islet of Langerhans—type 2 diabetes mellitus	0.0222	0.0649	CbGeAlD
Dihydroxyaluminium—VDAC1—islet of Langerhans—type 2 diabetes mellitus	0.0211	0.0617	CbGeAlD
Dihydroxyaluminium—VDAC2—cardiovascular system—type 2 diabetes mellitus	0.0193	0.0563	CbGeAlD
Dihydroxyaluminium—VDAC2—kidney—type 2 diabetes mellitus	0.0188	0.0551	CbGeAlD
Dihydroxyaluminium—VDAC2—pancreas—type 2 diabetes mellitus	0.0187	0.0548	CbGeAlD
Dihydroxyaluminium—VDAC3—nephron tubule—type 2 diabetes mellitus	0.0179	0.0522	CbGeAlD
Dihydroxyaluminium—VDAC1—nephron tubule—type 2 diabetes mellitus	0.017	0.0497	CbGeAlD
Dihydroxyaluminium—VDAC2—adipose tissue—type 2 diabetes mellitus	0.017	0.0497	CbGeAlD
Dihydroxyaluminium—VDAC3—cardiovascular system—type 2 diabetes mellitus	0.016	0.0469	CbGeAlD
Dihydroxyaluminium—VDAC3—pancreas—type 2 diabetes mellitus	0.0156	0.0456	CbGeAlD
Dihydroxyaluminium—VDAC3—cortex of kidney—type 2 diabetes mellitus	0.0153	0.0447	CbGeAlD
Dihydroxyaluminium—VDAC1—cardiovascular system—type 2 diabetes mellitus	0.0153	0.0446	CbGeAlD
Dihydroxyaluminium—VDAC1—kidney—type 2 diabetes mellitus	0.0149	0.0437	CbGeAlD
Dihydroxyaluminium—VDAC1—pancreas—type 2 diabetes mellitus	0.0148	0.0434	CbGeAlD
Dihydroxyaluminium—VDAC1—cortex of kidney—type 2 diabetes mellitus	0.0145	0.0425	CbGeAlD
Dihydroxyaluminium—VDAC3—adipose tissue—type 2 diabetes mellitus	0.0141	0.0414	CbGeAlD
Dihydroxyaluminium—VDAC1—adipose tissue—type 2 diabetes mellitus	0.0135	0.0394	CbGeAlD
Dihydroxyaluminium—TNNC1—cardiovascular system—type 2 diabetes mellitus	0.0131	0.0383	CbGeAlD
Dihydroxyaluminium—VDAC2—liver—type 2 diabetes mellitus	0.0119	0.0348	CbGeAlD
Dihydroxyaluminium—TNNC1—adipose tissue—type 2 diabetes mellitus	0.0115	0.0337	CbGeAlD
Dihydroxyaluminium—VDAC3—liver—type 2 diabetes mellitus	0.00992	0.029	CbGeAlD
Dihydroxyaluminium—VDAC1—liver—type 2 diabetes mellitus	0.00943	0.0276	CbGeAlD
Dihydroxyaluminium—Hyponatraemia—Glipizide—type 2 diabetes mellitus	0.00492	0.00747	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Orlistat—type 2 diabetes mellitus	0.00482	0.00732	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	0.00459	0.00697	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00453	0.00688	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.00435	0.00661	CcSEcCtD
Dihydroxyaluminium—Coma—Gliclazide—type 2 diabetes mellitus	0.00426	0.00647	CcSEcCtD
Dihydroxyaluminium—Back pain—Linagliptin—type 2 diabetes mellitus	0.00426	0.00647	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00411	0.00624	CcSEcCtD
Dihydroxyaluminium—Vertigo—Tolazamide—type 2 diabetes mellitus	0.00399	0.00607	CcSEcCtD
Dihydroxyaluminium—Back pain—Nateglinide—type 2 diabetes mellitus	0.00398	0.00605	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.00398	0.00604	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.00395	0.006	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.00395	0.006	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.00392	0.00596	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.00391	0.00594	CcSEcCtD
Dihydroxyaluminium—Polyuria—Gliclazide—type 2 diabetes mellitus	0.00385	0.00586	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.00385	0.00585	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Glyburide—type 2 diabetes mellitus	0.00378	0.00575	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.00357	0.00543	CcSEcCtD
Dihydroxyaluminium—Infection—Linagliptin—type 2 diabetes mellitus	0.00357	0.00542	CcSEcCtD
Dihydroxyaluminium—Thirst—Gliclazide—type 2 diabetes mellitus	0.00356	0.0054	CcSEcCtD
Dihydroxyaluminium—Polyuria—Orlistat—type 2 diabetes mellitus	0.0035	0.00532	CcSEcCtD
Dihydroxyaluminium—Lightheadedness—Metformin—type 2 diabetes mellitus	0.00349	0.0053	CcSEcCtD
Dihydroxyaluminium—Oedema—Acarbose—type 2 diabetes mellitus	0.00349	0.0053	CcSEcCtD
Dihydroxyaluminium—Back pain—Repaglinide—type 2 diabetes mellitus	0.00345	0.00524	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	0.0034	0.00516	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Glipizide—type 2 diabetes mellitus	0.0034	0.00516	CcSEcCtD
Dihydroxyaluminium—Lightheadedness—Irbesartan—type 2 diabetes mellitus	0.00329	0.005	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Glipizide—type 2 diabetes mellitus	0.00327	0.00496	CcSEcCtD
Dihydroxyaluminium—Back pain—Rosiglitazone—type 2 diabetes mellitus	0.00326	0.00495	CcSEcCtD
Dihydroxyaluminium—Thirst—Orlistat—type 2 diabetes mellitus	0.00323	0.00491	CcSEcCtD
Dihydroxyaluminium—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00317	0.00481	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.00313	0.00475	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Valsartan—type 2 diabetes mellitus	0.00312	0.00474	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.00305	0.00463	CcSEcCtD
Dihydroxyaluminium—Chills—Glipizide—type 2 diabetes mellitus	0.00304	0.00462	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00303	0.00461	CcSEcCtD
Dihydroxyaluminium—Oedema—Repaglinide—type 2 diabetes mellitus	0.00291	0.00442	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00289	0.00438	CcSEcCtD
Dihydroxyaluminium—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00288	0.00438	CcSEcCtD
Dihydroxyaluminium—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00288	0.00438	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00286	0.00434	CcSEcCtD
Dihydroxyaluminium—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00285	0.00433	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.00285	0.00433	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.00282	0.00428	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00278	0.00422	CcSEcCtD
Dihydroxyaluminium—Urticaria—Acarbose—type 2 diabetes mellitus	0.00277	0.00421	CcSEcCtD
Dihydroxyaluminium—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.00275	0.00418	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.00275	0.00418	CcSEcCtD
Dihydroxyaluminium—Back pain—Pioglitazone—type 2 diabetes mellitus	0.00273	0.00415	CcSEcCtD
Dihydroxyaluminium—Infection—Rosiglitazone—type 2 diabetes mellitus	0.00273	0.00415	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	0.00268	0.00408	CcSEcCtD
Dihydroxyaluminium—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00267	0.00406	CcSEcCtD
Dihydroxyaluminium—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.00266	0.00404	CcSEcCtD
Dihydroxyaluminium—Back pain—Sitagliptin—type 2 diabetes mellitus	0.00265	0.00403	CcSEcCtD
Dihydroxyaluminium—Vertigo—Glipizide—type 2 diabetes mellitus	0.00265	0.00403	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00265	0.00402	CcSEcCtD
Dihydroxyaluminium—Nausea—Miglitol—type 2 diabetes mellitus	0.00263	0.004	CcSEcCtD
Dihydroxyaluminium—Dehydration—Metformin—type 2 diabetes mellitus	0.00263	0.004	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00259	0.00394	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00259	0.00393	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00257	0.0039	CcSEcCtD
Dihydroxyaluminium—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00254	0.00386	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.00253	0.00384	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Glyburide—type 2 diabetes mellitus	0.00251	0.00382	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00248	0.00377	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00248	0.00376	CcSEcCtD
Dihydroxyaluminium—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00247	0.00375	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00246	0.00373	CcSEcCtD
Dihydroxyaluminium—Polyuria—Ramipril—type 2 diabetes mellitus	0.00246	0.00373	CcSEcCtD
Dihydroxyaluminium—Oedema—Glipizide—type 2 diabetes mellitus	0.00241	0.00366	CcSEcCtD
Dihydroxyaluminium—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.0024	0.00365	CcSEcCtD
Dihydroxyaluminium—Dizziness—Tolazamide—type 2 diabetes mellitus	0.0024	0.00365	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00239	0.00362	CcSEcCtD
Dihydroxyaluminium—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00238	0.00362	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Metformin—type 2 diabetes mellitus	0.00238	0.00362	CcSEcCtD
Dihydroxyaluminium—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00237	0.0036	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00235	0.00357	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00234	0.00356	CcSEcCtD
Dihydroxyaluminium—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00231	0.00351	CcSEcCtD
Dihydroxyaluminium—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00231	0.00351	CcSEcCtD
Dihydroxyaluminium—Oedema—Pioglitazone—type 2 diabetes mellitus	0.00231	0.0035	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.0023	0.00349	CcSEcCtD
Dihydroxyaluminium—Infection—Pioglitazone—type 2 diabetes mellitus	0.00229	0.00348	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.00226	0.00343	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.00225	0.00342	CcSEcCtD
Dihydroxyaluminium—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00339	CcSEcCtD
Dihydroxyaluminium—Infection—Sitagliptin—type 2 diabetes mellitus	0.00222	0.00338	CcSEcCtD
Dihydroxyaluminium—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00222	0.00338	CcSEcCtD
Dihydroxyaluminium—Vomiting—Acarbose—type 2 diabetes mellitus	0.00222	0.00337	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00219	0.00333	CcSEcCtD
Dihydroxyaluminium—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00218	0.00332	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.00217	0.00329	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Valsartan—type 2 diabetes mellitus	0.00216	0.00328	CcSEcCtD
Dihydroxyaluminium—Nausea—Tolazamide—type 2 diabetes mellitus	0.00216	0.00327	CcSEcCtD
Dihydroxyaluminium—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00216	0.00327	CcSEcCtD
Dihydroxyaluminium—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00215	0.00327	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00214	0.00326	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00214	0.00325	CcSEcCtD
Dihydroxyaluminium—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00214	0.00325	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Losartan—type 2 diabetes mellitus	0.00212	0.00322	CcSEcCtD
Dihydroxyaluminium—Chills—Gliclazide—type 2 diabetes mellitus	0.0021	0.00319	CcSEcCtD
Dihydroxyaluminium—Hypotension—Glimepiride—type 2 diabetes mellitus	0.0021	0.00319	CcSEcCtD
Dihydroxyaluminium—Nausea—Acarbose—type 2 diabetes mellitus	0.00207	0.00315	CcSEcCtD
Dihydroxyaluminium—Pain—Glipizide—type 2 diabetes mellitus	0.00206	0.00313	CcSEcCtD
Dihydroxyaluminium—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00203	0.00308	CcSEcCtD
Dihydroxyaluminium—Infection—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00306	CcSEcCtD
Dihydroxyaluminium—Nausea—Nateglinide—type 2 diabetes mellitus	0.002	0.00303	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00199	0.00302	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00198	0.00301	CcSEcCtD
Dihydroxyaluminium—Back pain—Gliclazide—type 2 diabetes mellitus	0.00197	0.003	CcSEcCtD
Dihydroxyaluminium—Convulsion—Glyburide—type 2 diabetes mellitus	0.00197	0.00299	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Metformin—type 2 diabetes mellitus	0.00196	0.00298	CcSEcCtD
Dihydroxyaluminium—Pain—Sitagliptin—type 2 diabetes mellitus	0.00192	0.00291	CcSEcCtD
Dihydroxyaluminium—Urticaria—Glipizide—type 2 diabetes mellitus	0.00191	0.00291	CcSEcCtD
Dihydroxyaluminium—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00189	0.00288	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00188	0.00286	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00185	0.00282	CcSEcCtD
Dihydroxyaluminium—Oedema—Glyburide—type 2 diabetes mellitus	0.00185	0.00281	CcSEcCtD
Dihydroxyaluminium—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00185	0.00281	CcSEcCtD
Dihydroxyaluminium—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00183	0.00278	CcSEcCtD
Dihydroxyaluminium—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00182	0.00276	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.00182	0.00276	CcSEcCtD
Dihydroxyaluminium—Back pain—Valsartan—type 2 diabetes mellitus	0.00181	0.00275	CcSEcCtD
Dihydroxyaluminium—Back pain—Orlistat—type 2 diabetes mellitus	0.00179	0.00272	CcSEcCtD
Dihydroxyaluminium—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00178	0.00271	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.00178	0.00271	CcSEcCtD
Dihydroxyaluminium—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00178	0.0027	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00177	0.00269	CcSEcCtD
Dihydroxyaluminium—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00177	0.00268	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00176	0.00268	CcSEcCtD
Dihydroxyaluminium—Chills—Metformin—type 2 diabetes mellitus	0.00176	0.00267	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Losartan—type 2 diabetes mellitus	0.00174	0.00265	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00174	0.00265	CcSEcCtD
Dihydroxyaluminium—Hypotension—Glyburide—type 2 diabetes mellitus	0.00173	0.00263	CcSEcCtD
Dihydroxyaluminium—Nausea—Repaglinide—type 2 diabetes mellitus	0.00173	0.00263	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0017	0.00258	CcSEcCtD
Dihydroxyaluminium—Vertigo—Valsartan—type 2 diabetes mellitus	0.00168	0.00256	CcSEcCtD
Dihydroxyaluminium—Vertigo—Orlistat—type 2 diabetes mellitus	0.00166	0.00253	CcSEcCtD
Dihydroxyaluminium—Chills—Irbesartan—type 2 diabetes mellitus	0.00166	0.00252	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00166	0.00251	CcSEcCtD
Dihydroxyaluminium—Infection—Gliclazide—type 2 diabetes mellitus	0.00165	0.00251	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00165	0.00251	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00165	0.0025	CcSEcCtD
Dihydroxyaluminium—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00163	0.00248	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00162	0.00247	CcSEcCtD
Dihydroxyaluminium—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00245	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Metformin—type 2 diabetes mellitus	0.00161	0.00244	CcSEcCtD
Dihydroxyaluminium—Convulsion—Orlistat—type 2 diabetes mellitus	0.0016	0.00244	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.0016	0.00243	CcSEcCtD
Dihydroxyaluminium—Dizziness—Glipizide—type 2 diabetes mellitus	0.00159	0.00242	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00158	0.0024	CcSEcCtD
Dihydroxyaluminium—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00155	0.00236	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00154	0.00234	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00153	0.00233	CcSEcCtD
Dihydroxyaluminium—Vomiting—Glipizide—type 2 diabetes mellitus	0.00153	0.00233	CcSEcCtD
Dihydroxyaluminium—Oedema—Valsartan—type 2 diabetes mellitus	0.00153	0.00232	CcSEcCtD
Dihydroxyaluminium—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00153	0.00232	CcSEcCtD
Dihydroxyaluminium—Infection—Valsartan—type 2 diabetes mellitus	0.00152	0.00231	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00152	0.0023	CcSEcCtD
Dihydroxyaluminium—Oedema—Orlistat—type 2 diabetes mellitus	0.00151	0.00229	CcSEcCtD
Dihydroxyaluminium—Infection—Orlistat—type 2 diabetes mellitus	0.0015	0.00228	CcSEcCtD
Dihydroxyaluminium—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00149	0.00226	CcSEcCtD
Dihydroxyaluminium—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00148	0.00225	CcSEcCtD
Dihydroxyaluminium—Urticaria—Glyburide—type 2 diabetes mellitus	0.00147	0.00224	CcSEcCtD
Dihydroxyaluminium—Back pain—Losartan—type 2 diabetes mellitus	0.00147	0.00223	CcSEcCtD
Dihydroxyaluminium—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00145	0.0022	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00144	0.00218	CcSEcCtD
Dihydroxyaluminium—Nausea—Glipizide—type 2 diabetes mellitus	0.00143	0.00217	CcSEcCtD
Dihydroxyaluminium—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00143	0.00217	CcSEcCtD
Dihydroxyaluminium—Hypotension—Valsartan—type 2 diabetes mellitus	0.00143	0.00217	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Losartan—type 2 diabetes mellitus	0.00143	0.00217	CcSEcCtD
Dihydroxyaluminium—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00142	0.00216	CcSEcCtD
Dihydroxyaluminium—Pain—Gliclazide—type 2 diabetes mellitus	0.00142	0.00216	CcSEcCtD
Dihydroxyaluminium—Oedema—Metformin—type 2 diabetes mellitus	0.00139	0.00211	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00139	0.00211	CcSEcCtD
Dihydroxyaluminium—Infection—Metformin—type 2 diabetes mellitus	0.00138	0.0021	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00136	0.00207	CcSEcCtD
Dihydroxyaluminium—Vertigo—Losartan—type 2 diabetes mellitus	0.00136	0.00207	CcSEcCtD
Dihydroxyaluminium—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00134	0.00204	CcSEcCtD
Dihydroxyaluminium—Nausea—Glimepiride—type 2 diabetes mellitus	0.00133	0.00203	CcSEcCtD
Dihydroxyaluminium—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00133	0.00202	CcSEcCtD
Dihydroxyaluminium—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00132	0.00201	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00132	0.002	CcSEcCtD
Dihydroxyaluminium—Oedema—Irbesartan—type 2 diabetes mellitus	0.00131	0.002	CcSEcCtD
Dihydroxyaluminium—Infection—Irbesartan—type 2 diabetes mellitus	0.0013	0.00198	CcSEcCtD
Dihydroxyaluminium—Hypotension—Metformin—type 2 diabetes mellitus	0.0013	0.00198	CcSEcCtD
Dihydroxyaluminium—Pain—Orlistat—type 2 diabetes mellitus	0.00129	0.00196	CcSEcCtD
Dihydroxyaluminium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00196	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00128	0.00195	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00127	0.00193	CcSEcCtD
Dihydroxyaluminium—Oedema—Losartan—type 2 diabetes mellitus	0.00124	0.00188	CcSEcCtD
Dihydroxyaluminium—Infection—Losartan—type 2 diabetes mellitus	0.00123	0.00187	CcSEcCtD
Dihydroxyaluminium—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00123	0.00186	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00123	0.00186	CcSEcCtD
Dihydroxyaluminium—Urticaria—Valsartan—type 2 diabetes mellitus	0.00121	0.00184	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Losartan—type 2 diabetes mellitus	0.00121	0.00183	CcSEcCtD
Dihydroxyaluminium—Nausea—Bromocriptine—type 2 diabetes mellitus	0.0012	0.00183	CcSEcCtD
Dihydroxyaluminium—Urticaria—Orlistat—type 2 diabetes mellitus	0.0012	0.00182	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00119	0.00181	CcSEcCtD
Dihydroxyaluminium—Vomiting—Glyburide—type 2 diabetes mellitus	0.00118	0.00179	CcSEcCtD
Dihydroxyaluminium—Vertigo—Ramipril—type 2 diabetes mellitus	0.00117	0.00177	CcSEcCtD
Dihydroxyaluminium—Hypotension—Losartan—type 2 diabetes mellitus	0.00116	0.00175	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00114	0.00173	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00113	0.00171	CcSEcCtD
Dihydroxyaluminium—Convulsion—Ramipril—type 2 diabetes mellitus	0.00113	0.00171	CcSEcCtD
Dihydroxyaluminium—Pain—Irbesartan—type 2 diabetes mellitus	0.00112	0.00171	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00111	0.00169	CcSEcCtD
Dihydroxyaluminium—Urticaria—Metformin—type 2 diabetes mellitus	0.00111	0.00168	CcSEcCtD
Dihydroxyaluminium—Nausea—Glyburide—type 2 diabetes mellitus	0.0011	0.00167	CcSEcCtD
Dihydroxyaluminium—Dizziness—Gliclazide—type 2 diabetes mellitus	0.0011	0.00167	CcSEcCtD
Dihydroxyaluminium—Oedema—Ramipril—type 2 diabetes mellitus	0.00106	0.00161	CcSEcCtD
Dihydroxyaluminium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00106	0.00161	CcSEcCtD
Dihydroxyaluminium—Pain—Losartan—type 2 diabetes mellitus	0.00106	0.00161	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00105	0.00159	CcSEcCtD
Dihydroxyaluminium—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00104	0.00159	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00104	0.00158	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00103	0.00157	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00103	0.00157	CcSEcCtD
Dihydroxyaluminium—Dizziness—Valsartan—type 2 diabetes mellitus	0.00101	0.00154	CcSEcCtD
Dihydroxyaluminium—Dizziness—Orlistat—type 2 diabetes mellitus	0.000999	0.00152	CcSEcCtD
Dihydroxyaluminium—Hypotension—Ramipril—type 2 diabetes mellitus	0.00099	0.0015	CcSEcCtD
Dihydroxyaluminium—Nausea—Gliclazide—type 2 diabetes mellitus	0.000988	0.0015	CcSEcCtD
Dihydroxyaluminium—Urticaria—Losartan—type 2 diabetes mellitus	0.000982	0.00149	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000977	0.00148	CcSEcCtD
Dihydroxyaluminium—Vomiting—Valsartan—type 2 diabetes mellitus	0.000972	0.00148	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000968	0.00147	CcSEcCtD
Dihydroxyaluminium—Vomiting—Orlistat—type 2 diabetes mellitus	0.00096	0.00146	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000952	0.00145	CcSEcCtD
Dihydroxyaluminium—Dizziness—Metformin—type 2 diabetes mellitus	0.00092	0.0014	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000911	0.00138	CcSEcCtD
Dihydroxyaluminium—Nausea—Valsartan—type 2 diabetes mellitus	0.000908	0.00138	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000899	0.00137	CcSEcCtD
Dihydroxyaluminium—Nausea—Orlistat—type 2 diabetes mellitus	0.000897	0.00136	CcSEcCtD
Dihydroxyaluminium—Vomiting—Metformin—type 2 diabetes mellitus	0.000885	0.00134	CcSEcCtD
Dihydroxyaluminium—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000869	0.00132	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000846	0.00128	CcSEcCtD
Dihydroxyaluminium—Urticaria—Ramipril—type 2 diabetes mellitus	0.000842	0.00128	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000838	0.00127	CcSEcCtD
Dihydroxyaluminium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000835	0.00127	CcSEcCtD
Dihydroxyaluminium—Nausea—Metformin—type 2 diabetes mellitus	0.000827	0.00126	CcSEcCtD
Dihydroxyaluminium—Dizziness—Losartan—type 2 diabetes mellitus	0.000817	0.00124	CcSEcCtD
Dihydroxyaluminium—Vomiting—Losartan—type 2 diabetes mellitus	0.000786	0.00119	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000781	0.00119	CcSEcCtD
Dihydroxyaluminium—Nausea—Irbesartan—type 2 diabetes mellitus	0.00078	0.00119	CcSEcCtD
Dihydroxyaluminium—Nausea—Losartan—type 2 diabetes mellitus	0.000734	0.00112	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000725	0.0011	CcSEcCtD
Dihydroxyaluminium—Dizziness—Ramipril—type 2 diabetes mellitus	0.000701	0.00106	CcSEcCtD
Dihydroxyaluminium—Vomiting—Ramipril—type 2 diabetes mellitus	0.000674	0.00102	CcSEcCtD
Dihydroxyaluminium—Nausea—Ramipril—type 2 diabetes mellitus	0.00063	0.000957	CcSEcCtD
